Carlsmed, Inc. Common Stock
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more
Carlsmed, Inc. Common Stock (CARL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.054x
Based on the latest financial reports, Carlsmed, Inc. Common Stock (CARL) has a cash flow conversion efficiency ratio of -0.054x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.32 Million) by net assets ($98.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Carlsmed, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Carlsmed, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Carlsmed, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carlsmed, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mstc Limited
NSE:MSTCLTD
|
-0.209x |
|
Remedy Entertainment Oyj
PINK:RMDEF
|
0.111x |
|
GOME Retail Holdings Limited
PINK:GMELF
|
0.002x |
|
Beacon Minerals Limited
AU:BCN
|
0.096x |
|
Econocom Group SE
F:1E91
|
N/A |
|
US Masters Residential Property Fund
PINK:UMRRF
|
-0.013x |
|
AIC Mines Limited
PINK:IAUFF
|
0.160x |
|
Bahnhof AB (publ)
F:3B7
|
0.157x |
Annual Cash Flow Conversion Efficiency for Carlsmed, Inc. Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Carlsmed, Inc. Common Stock from 2023 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $98.87 Million | $-28.98 Million | -0.293x | -181.29% |
| 2024-12-31 | $-70.63 Million | $-25.47 Million | 0.361x | -4.85% |
| 2023-12-31 | $-46.13 Million | $-17.48 Million | 0.379x | -- |